Osteoarthritis Therapeutics Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Pfizer (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), GlaxoSmithKline (LON: GSK), Bayer (ETR: BAYN)

Registering a CAGR of 8.6% over the forecast period, the market value of Osteoarthritis Therapeutics is expected to reach US$ 12,400.70 million in the year 2027.

Osteoarthritis Therapeutics Market Overview

Osteoarthritis is caused by injury, obesity, and a variety of other factors. It causes severe joint pain and stiffness in the affected body part. Osteoarthritis symptoms include joint swelling, numbness in the legs and arms, and a decreased range of motion. The high prevalence of rheumatoid arthritis is expected to drive market growth.

The aging population is expected to drive the growth of the Osteoarthritis Therapeutics market. The most common type of arthritis in older people is osteoarthritis, which is also one of the leading causes of physical disability. The disease affects both men and women. The most common sites of osteoarthritis are the hands, lower back, neck, and weight-bearing joints such as knees, hips, and feet. Osteoarthritis affects only the joints and not the internal organs. As you get older, you are more likely to develop osteoarthritis. Excess weight, poor joint alignment, and putting undue strain on an already injured joint can all contribute to the development of osteoarthritis.

The growing number of osteoarthritis therapeutics cases provides an opportunity for pharmaceutical companies to introduce novel therapies and promising pipeline drugs, fueling the growth of the osteoarthritis treatment market. Furthermore, advances in treatment rates and the presence of well-established healthcare facilities are some of the factors influencing drug demand. Nonetheless, a significant financial burden and patent expiration are factors impeding the growth of this market.

The report aspects discussed the profile of the top manufacturers of the global Osteoarthritis Therapeutics market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined the Osteoarthritis Therapeutics Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.

Who are the Major Players in the Osteoarthritis Therapeutics Market?

Global Osteoarthritis Therapeutics includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Pfizer (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), GlaxoSmithKline (LON: GSK), Bayer (ETR: BAYN), Eli Lilly (NYSE: LLY), Novartis International AG (SWX: NOVN), Sanofi (EPA: SAN), Horizon Pharma (NASDAQ: HZNP), Abbott Laboratories (NYSE: ABT), Mylan (NASDAQ: VTRS), Daiichi Sankyo, Teva Pharmaceutical Industries Ltd. (TLV: TEVA), Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma and others.

Industry News and Updates:

• In the United States, the FDA has approved GSK's Voltaren Arthritis Pain for over-the-counter use.

February 17, 2020— GlaxoSmithKline (LSE/NYSE: GSK) announced that the FDA has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1 percent (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in adults in the hand, wrist, elbow, foot, ankle, or knee (18 years and older). Voltaren Arthritis Pain is the first and only prescription-strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain to be approved by the FDA.

What are the major Applications, Types, and Regions for the Osteoarthritis Therapeutics Market?

The market is segmented based on the type, applications, companies, and regions.

By Type, it is segmented into

• Knee Osteoarthritis


• Hip Osteoarthritis


• Hand Osteoarthritis


• Small Joint Osteoarthritis

By Application, it is segmented into

• Medical Care


• Personal Care

Osteoarthritis Therapeutics Market Regional Analysis

Cases of osteoarthritis are increasing in North America as a result of changing lifestyles, an increase in obesity cases, and an increase in the geriatric population. As a result, the region's use of treatment and drugs is increasing. The availability of better treatment options, increased public awareness, government reimbursement policies, and a willingness to seek treatment are all expected to contribute to the growth of the osteoarthritis treatment market in the region.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Osteoarthritis Therapeutics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Osteoarthritis Therapeutics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Osteoarthritis Therapeutics Market report scope?

Scope of the Report covers the Osteoarthritis Therapeutics Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Osteoarthritis Therapeutics Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.

Key Takeaways from this Osteoarthritis Therapeutics Report

• Evaluate Osteoarthritis Therapeutics market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at the country level - for product types, end-use applications, and different industries verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.


• Get in-depth insights on your competitor’s performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies to your processes.


• Get a quick outlook on the Osteoarthritis Therapeutics market entropy – M&As, deals, partnerships, and product launches of all key players for the past 5 years.


• Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.

Frequently Asked Questions

What is the study period of this market?

The Osteoarthritis Therapeutics Market is studied from 2017 - 2027.

What is the growth rate of the Osteoarthritis Therapeutics Market?

The Osteoarthritis Therapeutics Market is growing at a CAGR of 8.6% over the next 5 years.

Who are the key players in Osteoarthritis Therapeutics Market?

Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma

What regions does this Osteoarthritis Therapeutics Market report cover?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Osteoarthritis Therapeutics Market?

Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Small Joint Osteoarthritis

What are the major end-use applications of the Osteoarthritis Therapeutics Market?

Medical Care, Personal Care

 

All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.